Goodfellow Pharma

Goodfellow Pharma is a Philippines-based pharmaceutical company focused on commercializing affordable specialty medicines, particularly in nephrology and oncology. The company appears to operate primarily as an importer, distributor, and marketer of finished pharmaceutical products rather than as a discovery-stage biotech developer. Its portfolio includes supportive-care and therapeutic products such as epoetin alfa, enoxaparin sodium, iron sucrose, oxaliplatin, docetaxel, gemcitabine, pemetrexed, letrozole, erlotinib, filgrastim, and recombinant human thrombopoietin, alongside renal and adjunctive care products. Goodfellow Pharma emphasizes access to evidence-based medicines for Filipino patients and highlights oncology and renal care as its core commercial areas. Publicly available information indicates an established operating business in Pasig, Metro Manila serving the Philippine healthcare market.